41
Participants
Start Date
November 30, 2023
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
BNT314
Intravenous infusion
GZA Ziekenhuizen, Antwerp
CHU de Liège, Liège
Hospital Fund. Jiménez Dia, Madrid
Hospital HM Univ. Sanchinarro, Ensayos START, Madrid
Carolina BioOncology Institute, LLC, Huntersville
Clinica Universidad de Navarra, Pamplona
Cleveland Clinic, Cleveland
START Midwest, Grand Rapids
Rigshospitalet, Copenhagen
National Cancer Center Hospital East, Kashiwanoha
Hospital Quironsalud Barcelona (NEXT Barcelona), Barcelona
Royal Marsden Hospital - London, London
The Christie Hospital, Manchester
Northern Centre for Cancer Care, Newcastle
Lead Sponsor
Collaborators (1)
Genmab
INDUSTRY
BioNTech SE
INDUSTRY